P. 1
US Food and Drug Administration: out50 en

US Food and Drug Administration: out50 en

|Views: 70|Likes:
Publicado porFDA

More info:

Published by: FDA on Jan 19, 2008
Copyright:Attribution Non-commercial


Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less






If the assumption that increased antimicrobial use correlates with an increased
prevalence of antimicrobial resistance holds true, then information on the
consumption of antimicrobials in human and veterinary medicine, as feed additives,
or for phytosanitation purposes should provide insight into the relative contribution
of the four areas to the overall problem. Data by country might even point to a
correlation between consumption of individual antibiotics and the variations in
prevalence of resistance to each across the EU.

The amount of accurate information available, however, is limited and it is not
known whether the key factor is the total tonnage of active substance consumed or
the way in which antibiotics are administered (e.g. dose regimens, duration of
courses, in hospitals or in the community).

Consistent sources of information across the community have been difficult to find.
As a broad generalisation, FEDESA (1997) has provided data which shows that of
10493 tons of active ingredient antibiotic consumed during 1997, approximately
52% was used in human medicine, 33% in veterinary medicine and 15% in animal
production. (see Annex, Table 2).

You're Reading a Free Preview

/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->